Glaukos Corporation· GKOS

Corient Private Wealth LP Takes Position in Glaukos Corporation $GKOS

Corient Private Wealth LP acquired a new stake in Glaukos Corporation (NYSE: GKOS) during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 57,048 shares of the medical instruments supplier's stock, valued at approximately $7,973,000. Corient Private Wealth LP owned approximately 0.10% of Glaukos at the

Glaukos Corporation $GKOS Stock Holdings Trimmed by Algert Global LLC

Algert Global LLC lessened its holdings in shares of Glaukos Corporation (NYSE: GKOS) by 43.0% in the second quarter, according to its most recent filing with the SEC. The firm owned 30,871 shares of the medical instruments supplier's stock after selling 23,330 shares during the quarter. Algert Global LLC owned about 0.05% of

Glaukos (GKOS) Up 8% Since Last Earnings Report: Can It Continue?

Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock?

61,957 Shares in Glaukos Corporation $GKOS Purchased by Deutsche Bank AG

Deutsche Bank AG acquired a new stake in Glaukos Corporation (NYSE: GKOS) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 61,957 shares of the medical instruments supplier's stock, valued at approximately $8,659,000. Deutsche Bank AG owned about 0.11% of Glaukos at the

GKOS Stock Surges 67% Year to Date: What's Driving the Rally?

Glaukos' iDose TR momentum and Epioxa launch are driving record growth, higher 2026 guidance and a broader ophthalmology platform.

Glaukos Corporation (GKOS) PT Raised to $215 at Truist Securities

Glaukos price target raised to $195 from $165 at Piper Sandler

Glaukos price target raised to $178 from $138 at Wells Fargo

Glaukos Corporation (GKOS) PT Raised to $201 at Needham

Glaukos Corporation (GKOS) PT Raised to $150 at Needham